75. Cushing disease Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 205 / Drugs : 176 - (DrugBank : 45) / Drug target genes : 61 - Drug target pathways : 127
Cushing disease and other diseases between which drug repositioning (DR) might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Score (Drug repositionability)
ID | Diseases (Sorted by score) | Score |
---|---|---|
75 | Cushing disease | - |
96 | Crohn disease | 22.933 |
13 | Multiple sclerosis/Neuromyelitis optica | 19.479 |
205 | Fragile X syndrome related disease | 17.290 |
152 | PCDH19 related syndrome | 16.000 |
6 | Parkinson disease | 15.946 |
46 | Malignant rheumatoid arthritis | 14.969 |
201 | Angelman syndrome | 14.196 |
2 | Amyotrophic lateral sclerosis | 14.151 |
145 | West syndrome | 13.742 |
231 | Alpha-1-antitrypsin deficiency | 12.976 |
158 | Tuberous sclerosis | 12.976 |
193 | Prader-Willi syndrome | 12.831 |
97 | Ulcerative colitis | 12.689 |
36 | Epidermolysis bullosa | 11.982 |
98 | Eosinophilic gastrointestinal disease | 11.929 |
272 | Fibrodysplasia ossificans progressiva | 11.434 |
22 | Moyamoya disease | 10.912 |
17 | Multiple system atrophy | 10.894 |
155 | Acquired aphasia with convulsive disorder | 10.679 |
84 | Sarcoidosis | 10.669 |
298 | Hereditary pancreatitis | 10.547 |
206 | Fragile X syndrome | 10.459 |
18 | Spinocerebellar degeneration | 10.335 |
21 | Mitochondrial disease | 10.118 |
8 | Huntington disease | 9.677 |
3 | Spinal muscular atrophy | 9.564 |
296 | Biliary atresia | 9.323 |
140 | Dorabe syndrome | 9.031 |
70 | Spinal stenosis | 8.710 |
34 | Neurofibromatosis | 8.700 |
144 | Lennox-Gastaut syndrome | 8.005 |
5 | Progressive supranuclear palsy | 7.888 |
156 | Rett syndrome | 7.385 |
74 | Prolactin secreting pituitary adenoma | 6.855 |
19 | Lysosomal storage disease | 6.101 |
299 | Cystic fibrosis | 5.406 |
67 | Polycystic kidney disease | 5.379 |
49 | Systemic lupus erythematosus | 4.492 |
78 | Hypopituitarism | 3.519 |
81 | Congenital adrenal hyperplasia | 3.290 |
86 | Pulmonary arterial hypertension | 2.947 |
113 | Muscular dystrophy | 2.480 |
94 | Primary sclerosing cholangitis | 2.292 |
72 | Pituitary ADH secretion disorder | 2.286 |
37 | Generalised pustular psoriasis | 2.206 |
77 | Growth hormone secreting pituitary adenoma | 2.000 |
225 | Congenital nephrogenic diabetes insipidus | 1.665 |
233 | Wolfram syndrome | 1.619 |
218 | Alport syndrome | 1.573 |
187 | Kabuki syndrome | 1.355 |
265 | Lipodystrophy | 1.287 |
65 | Primary immunodeficiency | 1.273 |
64 | Thrombotic thrombocytopenic purpura | 1.194 |
51 | Scleroderma | 1.175 |
222 | Primary nephrotic syndrome | 1.114 |
301 | Macular dystrophy | 1.097 |
288 | Autoimmune acquired coagulation factor deficiency | 1.090 |
66 | IgA nephropathy | 1.060 |
238 | Vitamin D-resistant rickets | 1.032 |
235 | Hypoparathyroidism | 1.032 |
191 | Werner syndrome | 1.000 |
220 | Rapidly progressive glomerulonephritis | 1.000 |
30 | Distal myopathy | 1.000 |